chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature of 99.0 (Fever); Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature of 99.0 (Fever)) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Temperature of 99.0 (Fever)) and HEADACHE (Headache). At the time of the report, PYREXIA (Temperature of 99.0 (Fever)) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: 99.0 f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Headache, Myalgia, Diarrhea, Nausea Vomiting, chills, fatigue, arm soreness Narrative: Sore arm, myalgia, diarrhea, chills, nausea, headache, fatigue; took Zofran Phenergan, tylenol, BC powders, imatrex; 12 hours resolved, no outside medical care.
Pt give vaccinations on Thurs. 8/19/10. Developed swollen upper arms-hot to touch and red on Friday 8/20. Seen in clinic on Sat. 8/21. -Cool compresses and MOTRIN given.
Headache, chills, coughing, fatigue, nausea, excessive urination.
2 days post vaccine, presence of urticarial lesions were noted on trunk and extremities.
4 hrs post administration pt reports feeling dizzy, nauseated, subjective fever that continued thru the night. Seen next am-temp 99.1. BP 116/74 exam nl and Rxn at injection site. Temp up to 101 that day by next am pt was fine.
I have a small cluster of bumps with a some kind of fluid in them at the injection site that begin itching about 3 days ago. Two days ago I noticed that I have additional small clusters of bumps on my left shoulder and these cluster are spreading down on the left side of my back and they continue to itch.  This begin to happen 12 days after my 2nd Moderna shot.  I am continuing to check my body to see if these clusters will spread even further.  I have also been nauseated early in the morning for about a week.  I am reporting these symptoms because the nausea, small cluster of liquid filled bumps and itching  is getting progressively slow and I am not sure if it is related to the Moderna Vaccination: but I never had these symptoms before.  Also, there have been no new foods eaten, or any life-stly changes and I have continued to always wear a mask whenever I leave my home.
Patient stated has had symptoms of headache, painful vision upon movement, lymph pain, erythema of injection site, oozing of injection site, cross inoculation, swelling, feverish, shivers, and lightheadedness.
On 7/27/23, during immunization reconciliation, the counts for specific lots of Pediatric MMR vaccine and Pediatric MMRV vaccine in system were noted to be discrepant from the physical Count of inventory in the clinic. MMRV (Lot: X007087 Exp: 9/4/24) was showing in system as having 10 doses in inventory with no doses having been administered, however, the physical count revealed only 9 doses in clinic. MMR (Lot: W007041 Exp: 02/29/2024) was showing in system as having 6 doses remaining, however, physical count of the vaccine in the unit was 7 doses. All other inventory counts were correct. 4 patients had documentation in system showing vaccination with this lot of MMR, since last reconciliation. All 4 patients were also vaccinated with Varicella vaccine during each of their visits. Documentation for each of the 4 patients also noted the MMR (and Varicella) vaccinations. Due to the discrepancies in count, however, it can be presumed that one of these children (although we cannot determine which child) were vaccinated with MMRV in the place of MMR and therefore received MMRV and Varicella on the same day inadvertently. RN reported findings to supervisor. Immunization Program Nurse and Regional Director were notified by RN. Dr. was also noted of above information. PHN contacted parents of all 4 minor patients and notified them of the possibility of vaccination error. Mom states that the child only had mild low-grade temperature and diarrhea for the remainder of the day after receiving the vaccines. No other reactions were reported. Child is currently doing fine.
Developed a lump on her leg, below her knee; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Developed a lump on her leg, below her knee) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (Developed a lump on her leg, below her knee). At the time of the report, PERIPHERAL SWELLING (Developed a lump on her leg, below her knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication reported.
Thyroditis; thyroid went hyper; hyperthyroid; High fever; Fast heartbeat; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A 50 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in hand left, administration date 01Mar2021 (Batch/Lot number: unknown) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The following information was reported: HYPERTHYROIDISM (medically significant) with onset Mar2021, outcome "unknown", described as "Thyroditis; thyroid went hyper; hyperthyroid"; PYREXIA (non-serious) with onset Mar2021, outcome "unknown", described as "High fever"; HEART RATE INCREASED (non-serious) with onset Mar2021, outcome "unknown", described as "Fast heartbeat". The patient underwent the following laboratory tests and procedures: blood test: (2021) hyperthyroid. Therapeutic measures were taken as a result of hyperthyroidism, pyrexia included Prednisone, Ibuprofen and Tylenol. clinical course: Basically 2 weeks after the vaccine patient had thyroiditis. The thyroid went hyper, all blood test (Further not clarified) on thyroid came like patient had a hyperthyroid, which patient never had before so that's why patient never had the 2nd vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
After 2nd vaccine, I became very ill with fever, chills for 2 days and it tapered off. I felt terrible. A week later I immediately had shortness of breath with extreme chest congestion. Walking 50 yards would take all of my energy. Recovered after 4 months. I saw multiple doctors. Urgent Clinic was the first provider I saw when the event started. I was having a lot of body aches during this time frame. I referred to it as a flare up as I would get 90% over this and then fall back into it again. The body aches were extreme and my chest felt like it was burning for an entire year. I still have the feeling as well. I was having burning in my kidneys so I went to a urologist. I have run so many test and the doctors still have been unable to determine why I am having these symptoms. The burning sensation in my kidneys did go away. The symptoms would feel like a UTI but eventually went away. I still have shortness of breath also. I been sick twice since the summer and it was pretty severe.
It has been more than a week later and the patient reports redness on the arm and itching. Suggested for the patient to apply BENADRYL cream to the area.
Shingles vaccination 7/1/09; 7/2/09 the patient reports fever, chills, muscle aches, then red tender sore arm at injection site.
Found to be positive with COVID-19 a second time (this time post-vaccination; first time in 5/2020). Symptoms included dyspnea with ADLs, decreased functionality/cognitive ability, and confusion over the past 2 weeks. She required 2 L of oxygen by nasal cannula initially when admitted 8/2, but has been on room air since 8/4. She received dexamethasone 6 mg PO daily x 4 days.
Office Visit 3/26/2021 Urgent Care  Family Medicine Viral respiratory illness +1 more Dx Headache  Reason for Visit Progress Notes (Physician Assistant)  Family Medicine ? ? Encounter Date: 3/26/2021 ? ? Signed    Assessment/Plan   Patient was seen today for headache.   Diagnoses and all orders for this visit:   Viral respiratory illness   Exposure to COVID-19 virus -     COVID-19 PCR; Future     History  Chief Complaint Patient presents with ? Headache     Headache, sore throat, COVID+ exposure   HPI  Patient is a female with history of type 2 diabetes presenting today for respiratory illness x today.  She reports having a headache, sore throat, runny nose and a cough.  No fevers or vomiting or diarrhea.  She has not been taking any over-the-counter medications.  She notes that her husband tested positive for COVID-19 last night and her son is currently sick with similar symptoms.  No history of asthma or COPD.  Patient has been checking her blood sugars, this morning it was 190.    ROS Review of Systems  Constitutional: Positive for chills. Negative for activity change, appetite change and fatigue.  HENT: Positive for sore throat. Negative for congestion, ear pain and rhinorrhea.   Respiratory: Negative for cough, chest tightness and shortness of breath.   Cardiovascular: Negative for chest pain.  Gastrointestinal: Negative for abdominal pain, diarrhea and vomiting.  Musculoskeletal: Negative for gait problem.  Skin: Negative for rash.  Allergic/Immunologic: Negative for environmental allergies and food allergies.  Neurological: Positive for headaches. Negative for dizziness.  Psychiatric/Behavioral: Negative for confusion.
COULD NOT SLEEP AS TOSSING AND TURNING ALL NIGHT; BODY ACHES; BODY SHAKING; CHILLS AND SHIVERING; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 33 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 03-MAY-2021 16:10 for prophylactic vaccination. No concomitant medications were reported. On 03-MAY-2021 23:30, the subject experienced could not sleep as tossing and turning all night. On 03-MAY-2021 23:30, the subject experienced body aches. On 03-MAY-2021 23:30, the subject experienced body shaking. On 03-MAY-2021 23:30, the subject experienced chills and shivering. On 03-MAY-2021 23:30, the subject experienced headache. On 03-MAY-2021 23:30, the subject experienced fever. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not sleep as tossing and turning all night, body shaking, and chills and shivering on 04-MAY-2021, and had not recovered from fever, body aches, and headache. This report was non-serious.
I have just a rash from head to toe; This is a spontaneous report from a contactable consumer or other non hcp. A 57-years-old female patient received bnt162b2 (BNT162B2) formulation solution for injection, dose 1 (Lot Number: ER8727; Expiration Date: 01Jul2021) via an unspecified route of administration on 23Mar2021 as dose 1 single for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease, dyspnoea from an unknown date and unknown if ongoing. Concomitant medication(s) included atorvastatin (ATORVASTATIN), sulfamethoxazole, trimethoprim (BACTRIM) taken for an unspecified indication, start and stop date were not reported; fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY) taken for dyspnoea, start and stop date were not reported. Consumer stated, "she doesn't know what that is of top her head, just one dose a day for her breathing." Consumer stated, "Well she had her first dose of the vaccine on Tuesday Morning, and Today she had just a rash from head to toe on 28Mar2021, and she want to know is this kind of normal thing, after having a vaccine or what she should be aware of, give her some guidance here. When probed if still experiencing the events, Consumer stated, "Yes, it's all over." Treatment: Consumer stated, "she just took some allergy tablets." Outcome of the events was not recovered.    No follow-up attempts are possible. No further information is expected.
Pt recvd vax & began to exp a serum sickness type react consisting of joint pain, weakness &/or diarrhea; workup has included numerous tests for collagen vascular disease & been non-diagnostic;
diarrhea; dizziness; chills; pain at injection site; This is a spontaneous report from a contactable consumer. This 66-year-old female consumer (patient) reported for herself.  A 66-year-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number and Expiration date was unknown), via an unspecified route of administration in left arm, on 23Feb2021 at 09:00 Am (patient was 66-year-old at the time of vaccination) at a single dose for covid-19 immunization (at the age of 66 years). The patient's medical history included allergy to penicillin. The patient's concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. She did not receive any other medications in two weeks. Neither the patient had covid-19 prior to vaccination, nor tested for covid post vaccination. On 23Feb2021 at 06:00 Pm, the patient experienced pain at injection site, chills, dizziness, and diarrhoea. Patient did not receive any treatment for events. The outcome of events were recovering.  Information about Lot/Batch number has been requested. Follow-up attempts completed. No further information expected.
A report has been received from a Health Professional concerning a 9 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 08-Apr-2014. Health Professional reported the patient received expired FLUMIST (expiry date: 07-Apr-2014) on 08-Apr-2014. The outcome of the event of EXPIRED FLUMIST ADMINISTERED is unknown. The report was considered to be non-serious.
Patient developed and continues to experience significant pain at the injection site that began within hours of receiving the flu shot. Condition has been physician diagnosed as an inflamed muscle/tendinitis leading to pronounced muscle weakness in the affected arm.  Patient has received a cortisone shot and has been undergoing physical therapy, but the pain is continuing.
Within hours of receiving my Typhoid vaccination, I developed intense itching and errythema at the injection site on my left arm.  Over the course of 4 days the injection site progressed to a wheel 9cm in diameter.  These symptoms (errythema, warmth, itching) continued despite the use of zyrtec, benedryl, and hyrocortisone cream.
Pt's "lips turned blue"-parents took baby to hospital where a work up was done. Doctor told parents initially that it could be a vaccine reaction. Later, pt was examined by a cardiologist who told parents, baby has a heart murmur and is to follow up w/ both the MD and cardiologist. Per follow-up information: Pulmonic valve stenosis, Atrial septal defect.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 64-year-old male patient who received SHINGRIX. Concurrent medical conditions included rash. Concomitant products included Atorvastatin, Losartan and Metformin. On 30th March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 4th April 2018, 5 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the patient experienced rash. On an unknown date, the outcome of the shingles was unknown and the outcome of the rash was not recovered/not resolved. It was unknown if the reporter considered the shingles and rash to be related to SHINGRIX. Additional details were provided as follows: The patient noticed a rash prior to receiving SHINGRIX. The patient received SHINGRIX in an unknown deltoid at the patient's doctor's office. On 4th April 2018, the patient went to his dermatologist because rash was not resolving and the patient diagnosed with shingles at that time.
Started yesterday, 7/14/2022 home from work tired and some muscle aches. 7/15/2022 right leg aches felt dizzy felt like throwing up and slight headache and sweating. Took ibuprofen general achiness in body.
Injection site reaction, still ongoing as of 10/18/21, still not resolved.  Area  directly below injection site is warm, and initially very tender, although tenderness is slowly improving and now starting to itch.  No tracking, area is localized but not sharply demarcated.  Area is hard.  Plan to start icing the area as still unresolved after almost 3 days.  Area is roughly 10 cm x 4 cm  Area was examined by husband (who is an ID physician) to ensure was not extravasation of product or cellulitis (confirmed only injection site reaction).  Pt has also had angioedema reactions to mosquito bites, and severe redness (w/o induration) with PPD shots over time, so may have skin hypersensitivity to certain agents.  Reaction did not occur with 1st 2 COVID vaccines
Significant right arm that was relieved with the use of OTC medications. Heat was also ineffective at relieving pain. Pt reports that she was unable to raise arm over her head without significant pain for over 2 weeks.
swelling in lt hand approx 5min p/vax sl numbness in fingertips @ that time;swelling more pronounced p/15min;no pitting;10:45 edema in hand et arm remains-no other sx;
pain in her arm to the wrist; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm to the wrist) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm to the wrist). At the time of the report, PAIN IN EXTREMITY (pain in her arm to the wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-134310 (Patient Link).
Received Menomune. W/i 30 minutes tender to touch, w/i 24 hours painful, red - "about the size of a soda can". Turned into a lump "about the size of a silver dollar" for 2 weeks.
On January 8, 2021 Pt presented to the clinic, COVID-19 vaccination facility in support to the local Department of Health. She underwent the usual screening interview where she was explained and clarified on questions about the Moderna vaccine plus a written informative sheet was provided for her to keep. At the end of this explanation a consent with her signature was collected to document her desire to voluntary receive the vaccine. At this station she was told that in order to receive this vaccine she should not had been vaccinated within the previous 14 days. Patient was then moved to the actual vaccination station where she was explained on what to expect after the shot and how to treat for fever or pain and to seek medical care if needed. Again, questions were clarified to her satisfaction. She was then injected intramuscularly on her right deltoid without complications. When the medical personnel were about to hand patient the card with the vaccine information and the date for the next booster to receive, she told to the medical person that she already had that card. She showed us the card and at that moment we realized that the Pt had received 0.5 ml Moderna COVID-19 vaccine on December 23rd at another facility operated by the local Department of Health. She was informed that she was supposed to receive second dose on January 20th, 2021 instead of January 8th. She was informed that she had completed the two-immunization scheduled for COVID-19 vaccine, although earlier than recommended. Patient was observed for 15 minutes after that. During that time, she did not experience any adverse reactions. She was told to seek medical help should she experience any medical problems.
3:30 am on 3/18/2021 injection site very sore. Flu like symptoms,headache,poor circulation in both arms. Symptoms worse same nite.
I started to experience fever chills sever headache and body aches. I got tested for COVID 3 times. I felt terrible for 48 hours and afterwards I had a full flare of psoriasis. This flare took at least 2 months to quiet down. I spoke with the provider via telehealth appointment. Then I received the 2nd dose and had a similar reaction with a flare which lasted a similar period of time.
Macular papular rash & pruritis to body - throat fullness. Do + MEDROL pak & Hydroxyzine PRN.